MS-Selfie

MS-Selfie

Home
Notes
MS-Selfie Research
MS-Selfie Microsite
Contact
Q&A
Archive
Leaderboard
About
Q&A 177 - Fampridine
How soon will I be allowed to be treated with fampridine on the NHS?
 • Gavin Giovannoni
Q&A 176: The EBV paradox in MS
Does this new study indicate ongoing active EBV lytic infection in MS, or not?
 • Gavin Giovannoni
Freeloading
Economics should trump what is actually best for people with MS; i.e. neurologists should prescribe rituximab over the more expensive innovator drugs as…
 • Gavin Giovannoni
Q&A 175: which anti-CD20 is best for me?
If you had multiple sclerosis, which anti-CD20 would you want to be treated with?
 • Gavin Giovannoni
Q&A 174: multiple sclerosis and psoriasis
I have seen a handful of patients who prioritise their treatment of psoriasis with one of the licensed biological therapies for psoriasis.
 • Gavin Giovannoni
Incidentalomas in Multiple Sclerosis
Every so often, a scan reveals something unrelated to your MS, such as a small cyst, a benign lump, a blood vessel variation, or a bit of inflammation…
 • Gavin Giovannoni
Q&A 173 - to be treated or not to be treated
I obviously don’t want to have any of these awful medications. Reading about people’s journeys, it seems they jump from one DMD to another.
 • Gavin Giovannoni
Q&A 172: the OVERLORD-MS study
Rituximab vs. Ocrelizumab; which is superior?
 • Gavin Giovannoni
Q&A 171 - social isolation in people with MS
Should I invest the time and effort in starting a digital relationship with an AI Chatbot?
 • Gavin Giovannoni
Can we cure MS?
The only way to find out is to define an MS cure and to look for it.
 • Gavin Giovannoni

June 2026

© 2026 Gavin Giovannoni · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture